About the Study

Hepatitis B Infection: A clinical study of tenofovir alafenamide in children and adolescents with long term hepatitis B infection

The purpose of this study is to see if Tenofovir Alafenamide is safe, tolerable, and effective in treating children and adolescents (2 to less than 18 years of age) with chronic (long term) hepatitis B virus infection.

Interested in learning more?

Full Study Name: Gilead Hepatitis B TAF Study